Thomas Malley's Net Worth

$12.2 Million

Estimate Recalculated Jul 8, 2024 03:17PM EST

Who is Thomas Malley?

Thomas Malley has an estimated net worth of $12.2 Million. This is based on reported shares across multiple companies, which include BeiGene, Ltd., Cougar Biotechnology, Inc., Kiniksa Pharmaceuticals, Ltd., Kura Oncology, Inc., PUMA BIOTECHNOLOGY, INC., OvaScience, Inc., and SYNAGEVA BIOPHARMA CORP.

SEC CIK

Thomas Malley's CIK is 0001403322

Past Insider Trading and Trends

2012 was Thomas Malley's most active year for acquiring shares with 10 total transactions. Thomas Malley's most active month to acquire stocks was the month of May. 2015 was Thomas Malley's most active year for disposing of shares, totalling 8 transactions. Thomas Malley's most active month to dispose stocks was the month of May. 2015 saw Thomas Malley paying a total of $2,318,982.07 for 135,755 shares, this is the most they've acquired in one year. In 2009 Thomas Malley cashed out on 59,918 shares for a total of $1,572,374.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BeiGene, Ltd. (BGNE) Snapshot price: $148.34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+38.26%
12.92K
—
—
46.7K
Jun 15
Form 4
+97.72%
16.69K
—
—
33.77K
Jun 22
Form 4
+84.03%
7.8K
—
—
17.08K
Jun 16
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 5
Form 4
∞
9.29K
—
—
9.29K
Jun 6
Form 4
—
0
—
—
0
Jun 2
Form 4
∞
30K
$32.00
$960,000.00
30K
Nov 23
Form 3
—
0
—
—
0
No matching records found

Cougar Biotechnology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-19.92K
$43.00
-$856,474.00
0
Jul 3
Form 4
—
0
—
—
0
Jun 17
Form 4
∞
19.92K
$21.75
$433,216.50
19.92K
Jul 17 - Jul 19
Form 4
—
0
—
—
0
Jun 12
Form 3
—
0
—
—
0
No matching records found

Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $18.235

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+87.46%
4.37K
—
—
9.37K
Jun 5 - Jun 6
Form 4
∞
5K
—
—
5K
Jun 29
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
May 29
Form 4
∞
71.97K
—
—
71.97K
May 29
Form 3
—
0
—
—
0
No matching records found

Kura Oncology, Inc. (KURA) Snapshot price: $20.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
+55.83%
50K
$11.50
$575,000.00
139.56K
Jun 16
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 25
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
May 12
Form 4
+126.40%
50K
$8.00
$400,000.00
89.56K
Nov 10
Form 4
—
0
—
—
0
Oct 13
Form 3
—
0
—
—
0
No matching records found

PUMA BIOTECHNOLOGY, INC. (PBYI) Snapshot price: $5.035

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Dec 19
Form 4
+6.82%
10K
$16.00
$160,000.00
156.55K
Oct 24
Form 4
—
0
—
—
0
Oct 18
Form 4
+7.35%
10.03K
$12.50
$125,400.00
146.55K
Jun 11
Form 4
+7.88%
9.97K
$12.50
$124,600.00
136.52K
Jun 7 - Jun 8
Form 4
—
0
—
—
0
Feb 13
Form 4
∞
126.55K
$3.75
$474,566.25
126.55K
Nov 18
Form 3
—
0
—
—
0
No matching records found